Cargando…
Engineering Nanoplatform for Combined Cancer Therapeutics via Complementary Autophagy Inhibition
Despite advances in the development of tumor treatments, mortality from cancer continues to increase. Nanotechnology is expected to provide an innovative anti-cancer therapy, to combat challenges such as multidrug resistance and tumor recurrence. Nevertheless, tumors can greatly rely on autophagy as...
Autores principales: | Wang, Xuan, Li, Yunhao, Lu, Jianqing, Deng, Xiongwei, Wu, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776236/ https://www.ncbi.nlm.nih.gov/pubmed/35054843 http://dx.doi.org/10.3390/ijms23020657 |
Ejemplares similares
-
Complementary autophagy inhibition and glucose metabolism with rattle-structured polydopamine@mesoporous silica nanoparticles for augmented low-temperature photothermal therapy and in vivo photoacoustic imaging
por: Shao, Leihou, et al.
Publicado: (2020) -
Self-assembled fluorescent hybrid nanoparticles-mediated collaborative lncRNA CCAT1 silencing and curcumin delivery for synchronous colorectal cancer theranostics
por: Jia, Fan, et al.
Publicado: (2021) -
Biointerface engineering nanoplatforms for cancer-targeted drug delivery
por: Zhang, Huaiyu, et al.
Publicado: (2020) -
Engineering exosomes as refined biological nanoplatforms for drug delivery
por: Luan, Xin, et al.
Publicado: (2017) -
Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics
por: Kim, Hyosuk, et al.
Publicado: (2020)